TMS.2.3.2004

More documents

Recommendations

Info

A14.6 Transfusionsmedicinske Standarder. Version 2.2 KT pos Donor indkaldes og informeres. Der tilbydes ny prøve (EIA og KT) og henvisning til klinisk ambulatorium. Ophører Figur A14.2 Algoritme ved undersøgelse for anti-HTLV-I/II KT pos Førstegangsdonor EIA pos Gentag EIA x 2 neg/pos pos/pos KT neg eller ink Informér ikke donor EIA og KT ved næste fremmøde 2. fremmøde EIA og KT neg © 1994-2004 Dansk Selskab for Klinisk Immunologi neg/neg Kassér blod Donor accepteres Se A14.420 KT neg
Transfusionsmedicinske Standarder. Version 2.2 A14.7 Figur A14.3 Algoritme ved undersøgelse for HBsAg pos Donor indkaldes og informeres. Der tilbydes ny prøve og henvisning til klinisk ambulatorium. Tilbagekaldelsesprocedure iværksættes Indikation for look-back vurderes Ophører Donorprøve EIA pos Gentag EIA x 2 neg/pos pos/pos Kassér blod Udfør anti-HBc anti-HBc neg Informér ikke donor Markér HBsAg og anti-HBc ved næste fremmøde 1. opfølgning HBsAg/ Anti-HBc pos neg/neg anti-HBc Anti-HBc og/eller HBV DNA pos pos/neg Informér ikke Markér HBsAg, anti-HBc og evt. HBV-DNA ved næste fremmøde 2. opfølgning HBsAg/ anti-HBc/ (HBV-DNA) pos/neg/(neg) Skriftlig information om tekniske problemer Pause neg neg/neg Kassér blod Kassér blod © 1994-2004 Dansk Selskab for Klinisk Immunologi Blodet anvendes Normale procedurer fremover neg/neg/(neg)
Page 1 and 2:
Transfusionsmedicinske Standarder V
Page 3 and 4:
Transfusionsmedicinske Standarder.
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176: Transfusionsmedicinske Standarder.
Page 225: Transfusionsmedicinske Standarder.
Page 249 and 250: A19.2 Transfusionsmedicinske Standa
Page 251 and 252: © 1994-2004 Dansk Selskab for Klin
Page 273 and 274: R.2 Transfusionsmedicinske Standard
Page 275 and 276: R.4 Transfusionsmedicinske Standard
Page 277 and 278:
R.6 Transfusionsmedicinske Standard
Page 279 and 280:
R.8 Transfusionsmedicinske Standard
Page 281 and 282:
R.10 Transfusionsmedicinske Standar
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
O.2 Transfusionsmedicinske Standard
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
O.10 Transfusionsmedicinske Standar
Page 299 and 300:
V.2 Transfusionsmedicinske Standard
Page 301 and 302:
V.4 Transfusionsmedicinske Standard
Page 303 and 304:
I.2 Transfusionsmedicinske Standard
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
I.10 Transfusionsmedicinske Standar
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
show all

TMS.2.3.2004

Create successful ePaper yourself

Delete template?

Save as template?